As of 2026-10-06, the EV/EBITDA ratio of Pliant Therapeutics Inc (PLRX) is -0.18. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PLRX's latest enterprise value is 38.89 mil USD. PLRX's TTM EBITDA according to its financial statements is -219.95 mil USD. Dividing these 2 quantities gives us the above PLRX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2026-10-02 | -0.18 |
| 2026-10-01 | -0.18 |
| 2026-09-30 | -0.19 |
| 2026-09-29 | -0.19 |
| 2026-09-28 | -0.19 |
| 2026-09-25 | -0.19 |
| 2026-09-24 | -0.21 |
| 2026-09-23 | -0.20 |
| 2026-09-22 | -0.21 |
| 2026-09-21 | -0.20 |
| 2026-09-18 | -0.20 |
| 2026-09-17 | -0.20 |
| 2026-09-16 | -0.19 |
| 2026-09-15 | -0.20 |
| 2026-09-14 | -0.21 |
| 2026-09-11 | -0.22 |
| 2026-09-10 | -0.20 |
| 2026-09-09 | -0.21 |
| 2026-09-08 | -0.21 |
| 2026-09-04 | -0.21 |
| 2026-09-03 | -0.20 |
| 2026-09-02 | -0.21 |
| 2026-09-01 | -0.20 |
| 2026-08-31 | -0.20 |
| 2026-08-28 | -0.20 |
| 2026-08-27 | -0.21 |
| 2026-08-26 | -0.21 |
| 2026-08-25 | -0.22 |
| 2026-08-24 | -0.21 |
| 2026-08-21 | -0.21 |
| 2026-08-20 | -0.20 |
| 2026-08-19 | -0.22 |
| 2026-08-18 | -0.21 |
| 2026-08-17 | -0.20 |
| 2026-08-14 | -0.19 |
| 2026-08-13 | -0.19 |
| 2026-08-12 | -0.19 |
| 2026-08-11 | -0.18 |
| 2026-08-10 | -0.18 |
| 2026-08-07 | -0.18 |
| 2026-08-06 | -0.18 |
| 2026-08-05 | -0.18 |
| 2026-08-04 | -0.18 |
| 2026-08-03 | -0.18 |
| 2026-07-31 | -0.18 |
| 2026-07-30 | -0.19 |
| 2026-07-29 | -0.18 |
| 2026-07-28 | -0.19 |
| 2026-07-27 | -0.19 |
| 2026-07-24 | -0.19 |